UK Markets open in 5 hrs 9 mins

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
167.84-0.92 (-0.55%)
At close: 04:00PM EST
167.60 -0.24 (-0.14%)
After hours: 07:52PM EST
Sign in to post a message.
  • R
    RoutineMidnight
    $JNJ aquiring $VXRT?
  • D
    DON
    Big Pharma needs this to protect their brand and their customers from dangerous counterfeit drugs. Anti-counterfeiting breakthrough being launched could be substantial windfall for shareholders. Just point smartphone and click and INSTANTLY know if it is real or fake. https://richardacavalli.wixsite.com/greenplanetmicrocaps
    THE END OF COUNTERFIETING IS HERE | Greenplanetmicrocaps
    richardacavalli.wixsite.com
  • M
    Mike
    Boosters are over. The World Health Organization: "A vaccination strategy based on repeated booster doses of the original vaccine composition is unlikely to be appropriate or sustainable."
  • L
    Lars Helge
    Is the JNJ high priced now?

    Thinking about it in my buy/keep portfolio, but as i can see it hase skyrocketed the last couple of years. I am building a dividend portfolio keeping for the long term

    What du you think? (I am a non US resident, and dont know the company well)
  • M
    Merrion
    JNJ facing lawsuits over talcum powder could be sued separately by 38k woman claiming health issues plus awarded Mexican gov over opioid sales there,sad for this pharmacy company and of course of any victims
  • B
    Biotechfan
    $INO conversation
    Reason for downturn..
    Supreme Court blocks nationwide vaccine and testing mandate for large businesses, allows health care worker vaccine mandate to take effect
    $mrna
    $bntx
    $cvac
    $nvax
    $pfe
    $jnj
    $azn
  • T
    The Abominable Snow Clown
    This could very well be $175 by Groundhog Day.
  • M
    Midnight Cowboy
    I would like some clarity on the fate of the dividend in respect to the company splitting into different public entities
  • L
    LA
    JNJ split may cause several issues to occur...biggest one being the dividend as it may be cut as part of the deal to ensure costs are covered. Another one is re-pricing my occur due to fall in revenues for the stock. GLTA. I will wait until after the split occurs and see what ends up happening.
  • G
    Guy
    Johnson & Johnson Stock (JNJ): $200 Price Target From Credit Suisse
    pulse2.com
  • I
    Iowa Joey
    $VXRT
    Here is what the "Bears" are saying about JnJ:

    J&J's late-stage drug pipeline is relatively weak for the size of the company, which could create long-term hurdles for growth.
    Several of J&J's important drugs are facing increasing competition, which could slow the growth rate of the drug group.

    Sounds like a $450B market cap Big Pharma needs some new blood. I think a $68B USD buyout of Vaxart would provide all the new growth they need for awhile. It's just an elevated walkway away.
  • C
    Chiara
    Trading forex is a good business one can think of doing
  • O
    OUCH
    What's up with the Yahoo price on JNJ stock...seems to have a "bug"....if it's automated?
  • G
    Grizzly Adams
    Are we buying Leronlimab for 25 billion ?
  • J
    Jack
    Buy JNJ and reinvest the Divs. Don’t over think investing. Trust your gut!
  • W
    Wisspur
    The market's most manipulated stock. It dropped more than it rose for no apparent reason.
  • M
    Midnight Cowboy
    Has the company addressed the dividend payout post breakup?
  • J
    John
    $PLTR conversation
    yes, good luck. I hope you all have a plan as to what you will do during this phase of correction.
    Or called crash! No one knows when it will end but it may stay as longer than previous crash!
    I do have some cash on the side and will be pull out with some losses...etc. Only thing I am holding is $tsla and $nio and $JNJ, $KMI, $SLB, and KO!
    Good luck people!
  • M
    Midnight Cowboy
    The vaccine is not an issue. I am more concerned with what my investment will look like when the company is split up.
  • K
    King James XIV
    $CYDY conversation
    Nothing to report on the $JNJ board